Literature DB >> 25626706

A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy.

Siaw H Wong1,2, Belinda J McClaren1, Alison Dalton Archibald1,2,3, Alice Weeks1, Tess Langmaid1, Monique M Ryan1,2,4, Andrew Kornberg1,2,4, Sylvia A Metcalfe1,2.   

Abstract

The delayed diagnosis of Duchenne muscular dystrophy (DMD) may be an ongoing problem internationally. We aimed to ascertain age at diagnosis and explore parents' experiences of the diagnosis of DMD in Australia. Using mixed methods, data were collected from laboratory and clinical record audits of testing for DMD in Victoria and Tasmania, interviews and a national survey of parents regarding their experiences from first noticing symptoms to receiving a diagnosis. The audits revealed that the median age at diagnosis for DMD was 5 years (n=49 during 2005-2010); this age had not changed substantially over this period. Fourteen parents interviewed reported age at diagnosis ranging from 2 to 8 years with a 6 month to 4 year delay between initial concerns about their child's development and receiving the DMD diagnosis. Sixty-two survey respondents reported the median age at diagnosis was 3 years and 9 months, while the median age when symptoms were noticed was 2 years and 9 months. Parents experienced many emotions in their search for a diagnosis and consulted with a wide range of health professionals. Half the survey respondents felt that their child could have been diagnosed earlier. Despite advances in testing technologies and increasing awareness of DMD, the age at diagnosis has remained constant in Australia. This mixed methods study shows that this diagnostic delay continues to have a negative impact on parents' experiences, places families at risk of having a second affected child and may have a deleterious effect on affected children's treatment.

Entities:  

Mesh:

Year:  2015        PMID: 25626706      PMCID: PMC4592094          DOI: 10.1038/ejhg.2014.301

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  26 in total

1.  Corticosteroids and Duchenne muscular dystrophy: does earlier treatment really matter?

Authors:  Craig M McDonald; Jay J Han; Jean K Mah; Gregory T Carter
Journal:  Muscle Nerve       Date:  2012-06       Impact factor: 3.217

Review 2.  Therapeutic restoration of dystrophin expression in Duchenne muscular dystrophy.

Authors:  Dominic J Wells
Journal:  J Muscle Res Cell Motil       Date:  2006-07-28       Impact factor: 2.698

3.  Evidence-based path to newborn screening for Duchenne muscular dystrophy.

Authors:  Jerry R Mendell; Chris Shilling; Nancy D Leslie; Kevin M Flanigan; Roula al-Dahhak; Julie Gastier-Foster; Kelley Kneile; Diane M Dunn; Brett Duval; Alexander Aoyagi; Cindy Hamil; Maha Mahmoud; Kandice Roush; Lauren Bird; Chelsea Rankin; Heather Lilly; Natalie Street; Ram Chandrasekar; Robert B Weiss
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

4.  Problems and potential for gene therapy in Duchenne muscular dystrophy.

Authors:  B A Kakulas
Journal:  Neuromuscul Disord       Date:  1997-07       Impact factor: 4.296

Review 5.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

6.  Delayed developmental language milestones in children with Duchenne's muscular dystrophy.

Authors:  Shana E Cyrulnik; Robert J Fee; Darryl C De Vivo; Edward Goldstein; Veronica J Hinton
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

7.  Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

Authors:  Emma Ciafaloni; Deborah J Fox; Shree Pandya; Christina P Westfield; Soman Puzhankara; Paul A Romitti; Katherine D Mathews; Timothy M Miller; Dennis J Matthews; Lisa A Miller; Christopher Cunniff; Charlotte M Druschel; Richard T Moxley
Journal:  J Pediatr       Date:  2009-04-25       Impact factor: 4.406

Review 8.  Multiplicity of experimental approaches to therapy for genetic muscle diseases and necessity for population screening.

Authors:  Nigel G Laing
Journal:  J Muscle Res Cell Motil       Date:  2008-12-30       Impact factor: 2.698

Review 9.  Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy.

Authors:  Lainie Friedman Ross
Journal:  Am J Med Genet A       Date:  2006-04-15       Impact factor: 2.802

Review 10.  Genetic treatments in muscular dystrophies.

Authors:  Francesco Muntoni; Dominic Wells
Journal:  Curr Opin Neurol       Date:  2007-10       Impact factor: 5.710

View more
  12 in total

Review 1.  Clinical management of Duchenne muscular dystrophy: the state of the art.

Authors:  Sonia Messina; Gian Luca Vita
Journal:  Neurol Sci       Date:  2018-09-14       Impact factor: 3.307

Review 2.  Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment.

Authors:  Qing Ke; Zheng-Yan Zhao; Robert Griggs; Veronica Wiley; Anne Connolly; Jennifer Kwon; Ming Qi; Daniel Sheehan; Emma Ciafaloni; R Rodney Howell; Petra Furu; Peter Sazani; Arvind Narayana; Michele Gatheridge
Journal:  World J Pediatr       Date:  2017-05-17       Impact factor: 2.764

3.  RNAseq analysis for the diagnosis of muscular dystrophy.

Authors:  Hernan Gonorazky; Minggao Liang; Beryl Cummings; Monkol Lek; Johann Micallef; Cynthia Hawkins; Raveen Basran; Ronald Cohn; Michael D Wilson; Daniel MacArthur; Christian R Marshall; Peter N Ray; James J Dowling
Journal:  Ann Clin Transl Neurol       Date:  2015-12-08       Impact factor: 4.511

4.  Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.

Authors:  Elizabeth Harris; Ana Topf; Rita Barresi; Judith Hudson; Helen Powell; James Tellez; Debbie Hicks; Anna Porter; Marta Bertoli; Teresinha Evangelista; Chiara Marini-Betollo; Ólafur Magnússon; Monkol Lek; Daniel MacArthur; Kate Bushby; Hanns Lochmüller; Volker Straub
Journal:  Orphanet J Rare Dis       Date:  2017-09-06       Impact factor: 4.123

5.  Genetic Testing among Children in a Complex Care Program.

Authors:  Krista Oei; Robin Z Hayeems; Wendy J Ungar; Ronald D Cohn; Eyal Cohen
Journal:  Children (Basel)       Date:  2017-05-22

6.  Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.

Authors:  Susanne Blöß; Christian Klemann; Ann-Katrin Rother; Sandra Mehmecke; Ulrike Schumacher; Urs Mücke; Martin Mücke; Christiane Stieber; Frank Klawonn; Xiaowei Kortum; Werner Lechner; Lorenz Grigull
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

7.  Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy.

Authors:  Shu Zhang; Dongdong Qin; Liwen Wu; Man Li; Lifang Song; Cuijie Wei; Chunling Lu; Xiaoli Zhang; Siqi Hong; Mingming Ma; Shiwen Wu
Journal:  Orphanet J Rare Dis       Date:  2021-04-28       Impact factor: 4.123

8.  Diagnostic Support for Selected Paediatric Pulmonary Diseases Using Answer-Pattern Recognition in Questionnaires Based on Combined Data Mining Applications--A Monocentric Observational Pilot Study.

Authors:  Ann-Katrin Rother; Nicolaus Schwerk; Folke Brinkmann; Frank Klawonn; Werner Lechner; Lorenz Grigull
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

9.  Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice.

Authors:  Buel D Rodgers; Yemeserach Bishaw; Denali Kagel; Julian N Ramos; Joseph W Maricelli
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-27       Impact factor: 6.698

10.  Prediagnosis pathway benchmarking audit in patients with Duchenne muscular dystrophy.

Authors:  Vasantha Lakshmi Gowda; Miguel Fernandez; Manish Prasad; Anne-Marie Childs; Imelda Hughes; Sandya Tirupathi; Christian Gaudentius Engelbert Lourens De Goede; Declan O'Rourke; Deepak Parasuraman; Tracey Willis; Samira Saberian; Ian Davidson
Journal:  Arch Dis Child       Date:  2021-07-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.